Marinus Pharmaceuticals I...
(MRNS)
undefined
undefined%
At close: undefined
0.25
-3.24%
Pre-market Dec 16, 2024, 04:27 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | 30.99M | 25.48M | 15.35M | 1.72M | - | - | - | - | - | - | - | 100.00K |
Cost of Revenue | 1.93M | 340.00K | 1.48M | 50.51M | 503.00K | 127.00K | 126.00K | 23.00K | 11.00K | - | - | - |
Gross Profit | 29.05M | 25.14M | 13.87M | -48.79M | -503.00K | -127.00K | -126.00K | -23.00K | -11.00K | - | - | 100.00K |
Operating Income | -131.49M | -112.79M | -96.93M | -67.94M | -54.42M | -37.18M | -19.04M | -28.24M | -24.43M | -11.92M | -5.38M | -1.43M |
Interest Income | 8.11M | 2.35M | 80.00K | 499.00K | 354.00K | 454.00K | 324.00K | 128.00K | 64.00K | 12.00K | 19.05K | 2.66K |
Pretax Income | -142.94M | -16.43M | -98.78M | -67.47M | -54.12M | -36.73M | -18.90M | -28.64M | -24.85M | -10.83M | -5.27M | -1.41M |
Net Income | -141.41M | -19.82M | -101.66M | -66.64M | -53.77M | -36.73M | -18.90M | -28.64M | -24.85M | -10.83M | -5.27M | -1.41M |
Selling & General & Admin | 61.15M | 56.84M | 37.28M | 18.55M | 11.46M | 8.79M | 6.67M | 6.24M | 5.52M | 3.23M | 1.23M | 685.10K |
Research & Development | 99.39M | 79.91M | 73.52M | 51.11M | 42.97M | 28.39M | 12.38M | 22.00M | 18.92M | 8.69M | 4.15M | 845.56K |
Other Expenses | - | 1.17M | 657.00K | -37.00K | -53.00K | -1K | -20.00K | -65.00K | -7.00K | 1.19M | 152.69K | 336.05K |
Operating Expenses | 160.54M | 137.93M | 110.80M | 69.66M | 54.42M | 37.18M | 19.04M | 28.24M | 24.43M | 11.92M | 5.35M | 1.53M |
Interest Expense | 16.89M | 10.67M | 2.58M | - | - | - | 159.00K | 464.00K | 475.00K | 117.00K | 90.61K | 320.78K |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 162.47M | 138.27M | 112.28M | 69.66M | 54.42M | 37.18M | 19.04M | 28.24M | 24.43M | 11.92M | 5.35M | 1.53M |
Income Tax | -1.54M | 3.39M | 2.88M | -833.00K | -354.00K | 453.00K | 13.00K | 399.00K | 468.00K | 1.31M | -27.82K | 656.83K |
Shares Outstanding (Basic) | 53.75M | 39.07M | 36.70M | 27.27M | 13.63M | 10.22M | 5.89M | 4.87M | 3.73M | 1.54M | 2.02M | 2.02M |
Shares Outstanding (Diluted) | 53.75M | 39.07M | 36.70M | 27.27M | 13.63M | 10.22M | 5.89M | 4.87M | 3.73M | 1.54M | 2.02M | 2.02M |
EPS (Basic) | -2.63 | -0.51 | -2.77 | -2.44 | -3.95 | -3.59 | -3.21 | -5.88 | -6.66 | -7.04 | -2.61 | -0.7 |
EPS (Diluted) | -2.63 | -0.51 | -2.77 | -2.44 | -3.95 | -3.59 | -3.21 | -5.88 | -6.66 | -7.04 | -2.61 | -0.7 |
EBITDA | -125.50M | -5.09M | -95.53M | -66.88M | -54.42M | -36.60M | -18.61M | -28.16M | -24.36M | -10.71M | -5.20M | -1.07M |
Depreciation & Amortization | 551.00K | 669.00K | 667.00K | 598.00K | 503.00K | 127.00K | 126.00K | 23.00K | 11.00K | 5.00K | 9.79K | 17.90K |